Bob Yedid | Investor Relations, Managing Director at LifeSci Advisors |
William Annett | President, Chief Executive Officer |
Mitch Levine | Chief Financial Officer |
Lyndal Hesterberg | Senior Vice President of Research & Development |
Bill Quirk | Piper Jaffray |
Paul Knight | Janney Montgomery Scott |
Bruce Jackson | The Benchmark Company |
Keay Nakae | Chardan Capital Markets |
Good day and welcome to the OncoCyte conference call to discuss fourth quarter and full year 2018 financial results and operating highlights. Today's call is being recorded. At this time, I would like to turn the call over to Bob Yedid of LifeSci Advisors. Please go ahead.
Thank you, operator and thank you everyone for joining us for this afternoon's conference call to discuss OncoCyte's fourth quarter and annual 2018 financial results and recent operating highlights.